3

PRIMARY DOCUMENT

Company: LIGAND PHARMACEUTICALS INC
Filed: April 20, 2011
Period of Report: April 18, 2011
Accession Number: 0000886163-11-000035

View Document ↗ View on SEC.gov ↗